[Federal Register Volume 69, Number 89 (Friday, May 7, 2004)]
[Notices]
[Pages 25589-25590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-04-51]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-E11, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Project

    Preventing Community-Associated Methicillin-Resistant 
Staphylococcus aureus (CA-MRSA) in Hawaii: Risk Factors and Outcomes 
for Infection in Children--New--National Center for Infectious Diseases 
(NCID), Centers for Disease Control and Prevention (CDC).
    CDC, National Center for Infectious Diseases is planning to 
implement a research study to identify: (1) Risk factors for CA-MRSA 
infections in children, (2) modifiable risks factors, and (3) culture-
specific issues to use in

[[Page 25590]]

the prevention of CA-MRSA infections among Pacific Islanders.
    S. aureus is one of the most common causes of serious skin and 
soft-tissue infections worldwide. Infections can be minor boils or 
abscesses, but often can progress to severe infections of muscle, bone, 
lung, or heart valves. Drug-resistant staphylococcal infections (MRSA) 
occur commonly among persons in hospitals and healthcare facilities. 
However, in the past few years these drug-resistant infections have 
caused illness in persons outside of healthcare setting in several 
states including Texas, Illinois, Minnesota, California, Georgia, 
Alaska, and most recently Hawaii.
    In 2002, the Hawaii Department of Health detected a high prevalence 
of MRSA using laboratory-based surveillance and began receiving reports 
from local clinicians of an increase of skin and soft tissue infections 
associated with MRSA among persons in the community. In September 2003, 
an epidemiologic investigation in Hawaii demonstrated there was an 
increase in the number of CA-MRSA infections between 2001 and 2003 with 
higher prevalence of these infections among Pacific Islanders, 
especially children. Likewise, reports from outside the United States 
have indicated that CA-MRSA infections may be more frequent in Pacific 
Islander populations; however, there are no appreciable Native 
Hawaiian/Pacific Islander groups represented at the sites conducting 
CDC-supported population-based surveillance for CA-MRSA. Identification 
of the risks factors in this population will greatly assist efforts to 
implement activities for prevention of CA-MRSA infections among Pacific 
Islanders. There will be no cost to the respondents.

----------------------------------------------------------------------------------------------------------------
                                                                      No. of        Avg. burden
                      Forms                           No. of       responses per   per response    Total burden
                                                    respondents     respondents     (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Telephone interview form 1......................             240               1           30/60             120
(cases and controls)............................
Follow-up telephone interview form..............             120               1           15/60              30
(cases only)....................................
                                                                                                 ---------------
    Total.......................................  ..............  ..............  ..............             150
----------------------------------------------------------------------------------------------------------------


    Dated: April 29, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-10420 Filed 5-6-04; 8:45 am]
BILLING CODE 4163-18-P